How Has The Size And Value Of The Heart Closure Devices Market Changed During The 2026–2030 Period?
The heart closure devices market size has grown rapidly in recent years. It will grow from $3.08 billion in 2025 to $3.46 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, expansion of catheterization laboratories, growing adoption of minimally invasive cardiac treatments, rising awareness of structural heart conditions, availability of advanced imaging guidance.
The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for catheter-based cardiac therapies, rising investments in structural heart disease treatment, expansion of specialized cardiac centers, growing focus on reducing surgical risks, technological advancements in closure device design. Major trends in the forecast period include increasing adoption of transcatheter heart closure procedures, rising demand for minimally invasive cardiac devices, growing use of nitinol-based closure systems, expansion of structural heart intervention programs, enhanced focus on procedural safety and efficacy.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Heart Closure Devices Market?
The increasing incidence of cardiovascular diseases (CVDs) is expected to propel the growth of the heart closure devices market going forward. The increasing incidence of cardiovascular diseases (CVDs) is driven by factors such as aging, unhealthy lifestyle choices, genetic predisposition, and increasing prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices help reduce the incidence of complications from congenital heart defects by minimally invasively closing abnormal openings in the heart, improving blood flow, and preventing further health issues. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, the total number of deaths from cardiovascular disease accounted for 26,885 in 2023. Moreover, ischemic heart disease resulted in 5,302 deaths, showing an increase from 5,290 deaths in 2022. Therefore, the increasing incidence of cardiovascular diseases (CVDs) is driving the growth of the heart closure devices market.
Which Primary Segments Are Included In The Detailed Analysis Of The Heart Closure Devices Market?
The heart closure devices market covered in this report is segmented –
1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery
4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices
2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices
4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices
5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices
Which Trends Are Expected To Steer The Evolution Of The Heart Closure Devices Market?
Major companies operating in the heart closure devices market are focusing on technological innovation, such as low-profile, ergonomic surgical LAA devices with continuous closing force mechanisms, to enhance procedural precision, visibility, and ease of use for physicians while improving patient outcomes. Low-Profile Surgical LAA Devices enable safe and effective closure of the left atrial appendage, providing optimal tissue compression, simplified single-handed placement, and enhanced access in minimally invasive procedures.For instance, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, launched first patient with its AtriClip FLEX-Mini device, the smallest-profile surgical LAA device on the market. Building on the proven AtriClip platform, the device features a fully enclosed design with parallel beams for continuous closing force, improved visibility, and an ergonomic handle for single-handed placement, supporting physicians in delivering precise, safe, and efficient LAA management for atrial fibrillation patients.
Which Major Corporations Play A Crucial Role In The Heart Closure Devices Market Landscape?
Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation
Get Your In-Depth Heart Closure Devices Market Report Now:
Which Regions Demonstrate The Highest Growth Momentum In The Heart Closure Devices Market?
North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment